ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
64,428.07
0.84%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Repare Therapeutics Inc (RPTX)

  7. Repare Therapeutics Inc (RPTX) Noticias

RPTX Repare Therapeutics Inc

3.45
0.10 (2.99%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Repare Therapeutics Inc RPTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.10 2.99% 3.45 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.48 3.445 3.74 3.45 3.35
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202406:05BWDEBIOPHARM ET REPARE THERAPEUTICS ANNONCENT LE TRAITEMENT..
26/4/202415:05BWRepare Therapeutics Appoints Steven H. Stein, M.D. to its..
05/3/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202406:05BWRepare Therapeutics to Participate in Two Upcoming Investor..
28/2/202415:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202406:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202406:10EDGAR2Form 8-K - Current report
28/2/202406:05BWRepare Therapeutics Provides Business Update and Reports..
15/2/202406:05BWRepare Therapeutics Doses First Patient in Phase 1 Clinical..
14/2/202420:02EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202407:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:48EDGAR2Form 8-K - Current report
12/2/202415:05BWRepare Therapeutics to Regain Global Rights to Camonsertib
25/1/202413:29EDGAR2Form 8-K - Current report
25/1/202406:00BWRepare Therapeutics Announces Achievement of $40 Million..
12/1/202415:05EDGAR2Form 8-K - Current report
08/1/202406:00BWRepare Therapeutics Provides Corporate Update and Highlights..
04/1/202415:05BWRepare Therapeutics and Debiopharm Partner to Explore the..
29/12/202315:05BWRepare Therapeutics Insiders Establish Automatic Securities..
12/12/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202306:20EDGAR2Form 8-K - Current report
15/11/202306:00BWRepare Therapeutics Unveils Two Programs Expected to Enter..
09/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:05EDGAR2Form 8-K - Current report
09/11/202306:00BWRepare Therapeutics Provides Business Update and Reports..
07/11/202306:00BWRepare Therapeutics to Host Investor and Analyst Conference..
06/11/202306:00BWRepare Therapeutics to Participate in Two Upcoming Investor..
13/10/202316:15EDGAR2Form 8-K - Current report
13/10/202308:47EDGAR2Form 8-K - Current report
13/10/202308:40BWRepare Therapeutics Announces Positive Initial Data from..
06/10/202306:56EDGAR2Form 8-K - Current report
03/10/202306:00BWRepare Therapeutics to Host Conference Call and Webcast to..
19/9/202306:00BWRepare Therapeutics to Present Preliminary Phase 1 MYTHIC..
06/9/202306:00BWRepare Therapeutics to Participate at the Morgan Stanley..
09/8/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:09EDGAR2Form 8-K - Current report
09/8/202315:05BWRepare Therapeutics Provides Business Update and Reports..
08/6/202306:00BWRepare Therapeutics to Participate at the Goldman Sachs 44th..
07/6/202315:05BWRepare Therapeutics Reports Proof of Concept for Lunresertib..
06/6/202306:00BWRepare Therapeutics Announces Publication in Nature Medicine..
02/6/202306:00BWRepare Therapeutics to Host Conference Call and Webcast to..
22/5/202306:00BWRepare Reports Inducement Grant Under Nasdaq Listing Rule..
09/5/202315:05BWRepare Therapeutics Provides Business Update and Reports..

Su Consulta Reciente

NASDAQ
RPTX
Repare Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados